Top Story

Postsurgical surveillance sufficient for stage I nonseminoma germ cell cancer

October 28, 2014

Most men with stage I nonseminoma germ cell cancer who undergo radical orchiectomy can be followed with surveillance, according to results of a retrospective study conducted in Denmark.

“Danish national data show that approximately 70% of patients with germ cell cancer have clinical stage I disease at presentation. Of these, 40% have nonseminoma [germ cell cancer],” the researchers wrote. “Without treatment, a significant proportion of patients with stage I disease will relapse. These relapses can be treated when they appear, or adjuvant therapies can be applied immediately after orchiectomy.”

Institution Notes

Mount Sinai names vice chairman of urology

October 14, 2014
Ketan Badani, MD, professor of urology at Icahn School of Medicine at Mount Sinai, has been named vice chairman of urology and robotic operations at Mount Sinai Health…
figure In the Journals

Radical cystectomy, urinary diversion increased fracture risk among patients with bladder cancer

October 8, 2014
Patients with bladder cancer who underwent radical cystectomy and urinary diversion demonstrated an increased risk for bone fracture, according to results of a…
figure EditorialPublication Exclusive

Not again … but I thought the government and Pharma said the problem was fixed?

HemOnc Today, October 25, 2014
Derek Raghavan, MD, PhD
Bladder cancer is one of the commonest malignancies in Western society.There are more than 75,000 new cases each year in the United States, and about 80% of incident…
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »

Filter By:

In the Journals

Postsurgical surveillance sufficient for stage I nonseminoma germ cell cancer

October 28, 2014
Most men with stage I nonseminoma germ cell cancer who undergo radical orchiectomy can be followed with surveillance, according to results of a…
Institution Notes

Mount Sinai names vice chairman of urology

October 14, 2014
Ketan Badani, MD, professor of urology at Icahn School of Medicine at Mount Sinai, has been named vice chairman of urology and robotic operations at…
figure In the Journals

Radical cystectomy, urinary diversion increased fracture risk among patients with bladder cancer

October 8, 2014
Patients with bladder cancer who underwent radical cystectomy and urinary diversion demonstrated an increased risk for bone fracture, according to…
figure Editorial Publication Exclusive

Not again … but I thought the government and Pharma said the problem was fixed?

HemOnc Today, October 25, 2014
Derek Raghavan, MD, PhD
Bladder cancer is one of the commonest malignancies in Western society.There are more than 75,000 new cases each year in the United States, and about…
figure In the Journals Perspective

Multidisciplinary approach may better detect, treat depression among patients with cancer

HemOnc Today, October 25, 2014
Major depression is common among patients with cancer — particularly those with lung cancer — yet it often goes untreated, according to a series of…
Meeting News Coverage

Safety, efficacy of sorafenib exposure inconsistent in HCC, RCC patients

September 29, 2014
There was no apparent relationship between exposure to sorafenib and safety and efficacy among patients with hepatocellular carcinoma or renal cell…
In the Journals

Zoledronic acid plus everolimus improved outcomes in renal cell carcinoma

September 26, 2014
The addition of zoledronic acid to everolimus significantly reduced bone resorption markers and extended tumor control in patients with renal cell…
figure Editorial Publication Exclusive

I’d like to agree with you … but then we’d both be wrong!

HemOnc Today, September 25, 2014
Derek Raghavan, MD, PhD
I sometimes fear that I am a natural curmudgeon, or at the very least a true cynic.If you have read my recent editorials and op-eds, it may seem I…
figure Meeting News Coverage Perspective

Shorter ADT regimen improved quality of life among men with high-risk prostate cancer

September 16, 2014
Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved…
figure

Report: Commitment to NIH, NCI funding only 'viable path' for continued success in cancer research

September 16, 2014
The scientific community’s continued quest to prevent and cure cancer has reached a crossroads, according to a report released today by the…
More Headlines »